Condition
Normal Skin
Total Trials
4
Recruiting
0
Active
0
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
25%
1 trials in Phase 3/4
Results Transparency
0%
0 of 3 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (2)
P 1 (1)
P 4 (1)
Trial Status
Completed3
Not Yet Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT07065149Not ApplicableNot Yet RecruitingPrimary
To Assess Skin Safety of Test Product(s) by Patch Test on Adult Healthy Human Subjects.
NCT06631898Not ApplicableCompletedPrimary
To Check Dermatological Safety of Test Products by 24 Hours Patch Test on Adult Healthy Human Subjects.
NCT02889159Phase 1Completed
Immunologic Profile of Chronically Photodamaged Skin
NCT04221126Phase 4CompletedPrimary
TMFI Enhances Skin Surface and Epidermal PpIX Fluorescence
Showing all 4 trials